Determination of plasma concentrations of endothelin-1(1-31) and endothelin-1 in healthy subjects and patients with atherosclerosis

Journal of Cardiovascular Pharmacology

Volumn 41, Issue SUPPL. 1, 2003, Pages

  Suzaki, Yuki ^a   Yoshizumi, Masanori ^a   Yamashita, Yukio ^a   Abe, Shinji ^a   Tsuchiya, Koichiro ^a   Satoh, Yumiko ^a   Kuroda, Yasuhiro ^a   Horike, Kazuya ^b   Kano, Masashi ^b   Fukata, Yoshio ^b   Kitaichi, Takashi ^a   Hori, Takaki ^a   Masuda, Yutaka ^a   Kitagawa, Tetsuya ^a   Minakuchi, Kazuo ^a   Tamaki, Toshiaki ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b National Hospital Organization   (Japan)

Author keywords

Atherosclerosis; Endothelin 1(1 31); Enzyme immunoassay; Plasma level

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN 1[1-31]; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; ADULT; AGED; ANEURYSM SURGERY; AORTA ANEURYSM; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR AUTOREGULATION; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME IMMUNOASSAY; HUMAN; MALE; PLASMA; PRIORITY JOURNAL;

ADULT; AGED; AORTIC ANEURYSM, ABDOMINAL; ARTERIOSCLEROSIS; ENDOTHELIN-1; HUMANS; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS;

EID: 12244258218     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (16)

1. Yanagisawa M, Kurihara H, Kimura S, et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988;332:411-5.
2. Goto K, Hama H, Kasuya Y. Molecular pharmacology and pathophysiological significance of endothelin. Jpn J Pharmacol 1996;72:261-90.
3. Nakano A, Kishi F, Minami K, et al. Selective conversion of big endothelins to tracheal smooth muscle-constricting 31-amino acidlength endothelins by chymase from human mast cells. J Immunol 1997;159:1987-92.
4. Tamaki T, Yoshizumi M, Houchi H, et al. Effect of newly discovered endothelin-1 (1-31) on the lumen diameter of afferent and efferent arterioles [abstract]. J Am Soc Nephrol 1997;8:339A.
5. i in human coronary artery smooth muscle cells. Eur J Pharmacol 1998;348:305-9.
6. Yoshizumi M, Kim S, Kagami S, et al. Effect of endothelin-1 (1-31) on extracellular signal-regulated kinase and proliferation of human coronary artery smooth muscle cells. Br J Pharmacol 1998;125:1019-27.
7. Okishima N, Hagiwara Y, Seito T, et al. Specific sandwich-type enzyme immunoassays for smooth muscle constricting novel 31-amino acid endothelins. Biochem Biophys Res Commun 1999;256:1-5.
8. Okishima N, Yoshizumi M, Tsuchiya K, et al. Determination of the levels of novel 31-amino acid endothelins and endothelins in human lungs. Life Sci 2001;68:2073-80.
9. Cernacek P, Stewart DJ. Immunoreactive endothelin in human plasma: Marked elevations in patients in cardiogenic shock. Biochem Biophys Res Commun 1989;161:562-7.
10. Widimsky J Jr, Horky K, Dvorakova J. Plasma endothelin-1,2 levels in mild and severe hypertension. J Hypertens Suppl 1991;9:S194-5.
11. Haug C, Koenig W, Hoeher M, et al. Direct enzyme immunometric measurement of plasma big endothelin-I concentrations and correlation with indicators of left ventricular function. Clin Chem 1998;44:239-43.
12. Sugiura M, Inagami T, Hare GM, et al. Endothelin action: Inhibition by a protein kinase C inhibitor and involvement of phosphoinositols. Biochem Biophys Res Commun 1989;158:170-6.
13. Bolger GT, Liard F, Jodoin A, et al. Vascular reactivity, tissue levels, and binding sites for endothelin: A comparison in the spontaneously hypertensive and Wistar-Kyoto rats. Can J Physiol Pharmacol 1991;69:406-13.
14. Wong M, Jeng AY. Determination of tissue endothelin levels. Biochem Mol Biol Int 1995;35:1359-64.
15. Predel HG, Knigge H, Prinz U, et al. The exercise-induced increase in plasma levels of endothelin-1 is enhanced in patients with atherosclerotic coronary artery disease. Modulation by pentaerithrityltetranitrat (PETN). Agents Actions Suppl 1995;45:219-25.
16. Cui P, Tani K, Kitamura H, et al. A novel bioactive 31-amino acid endothelin-1 is a potent chemotactic peptide for human neutrophils and monocytes. J Leukoc Biol 2001;70:306-12.